Abstract
More than 90% of malignant tumors arising in humans are of epithelial origin. The loss of epithelial morphology and the acquisition of mesenchymal characteristics are important early events in tumor progression. This type of morphological transformation is termed an epithelial-mesenchymal transition. These transitions occur normally during embryonic development, as well as pathologically during tumor progression. This review will encapsulate our understanding of the role that epithelial-mesenchymal transitions play during tumor progression and metastasis, and we also summarize recent results describing the roles played by such genes as E-cadherin, Snail, and TGFβ in regulating epithelial-mesenchymal transitions and metastasis.
Keywords: epithelial-mesenchymal, e-cadherin, snail, tgf
Current Genomics
Title: Epithelial-Mesenchymal Transitions and Cancer
Volume: 3 Issue: 4
Author(s): Ethan A. Carver and Thomas Gridley
Affiliation:
Keywords: epithelial-mesenchymal, e-cadherin, snail, tgf
Abstract: More than 90% of malignant tumors arising in humans are of epithelial origin. The loss of epithelial morphology and the acquisition of mesenchymal characteristics are important early events in tumor progression. This type of morphological transformation is termed an epithelial-mesenchymal transition. These transitions occur normally during embryonic development, as well as pathologically during tumor progression. This review will encapsulate our understanding of the role that epithelial-mesenchymal transitions play during tumor progression and metastasis, and we also summarize recent results describing the roles played by such genes as E-cadherin, Snail, and TGFβ in regulating epithelial-mesenchymal transitions and metastasis.
Export Options
About this article
Cite this article as:
Carver A. Ethan and Gridley Thomas, Epithelial-Mesenchymal Transitions and Cancer, Current Genomics 2002; 3 (4) . https://dx.doi.org/10.2174/1389202023350426
DOI https://dx.doi.org/10.2174/1389202023350426 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
QSAR and Docking Based Semi-Synthesis and In Vivo Evaluation of Artemisinin Derivatives for Antimalarial Activity
Current Drug Targets Effect of Dasatinib on Genes Related to Mitotic Catastrophe Pathway in Chronic Myeloid Leukemia Cells
Anti-Cancer Agents in Medicinal Chemistry Tumor Growth-Promoting Properties of Macrophage Migration Inhibitory Factor
Current Pharmaceutical Design Therapeutic Approaches for Combating <i>Aspergillus</i> Associated Infection
Current Drug Targets Cytotoxicity and Toxicological Studies of <i>Artocarpus altilis</i> Extracts, Inducing Apoptosis and Cell Cycle Arrest via <i>CASPASE-3</i> and <i>CASPASE-8</i> Pathways against Human Breast MCF-7 Cells
Combinatorial Chemistry & High Throughput Screening A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Antiproliferative Activity of Olive Oil Phenolics against Human Melan oma Cells
Letters in Drug Design & Discovery New Developments and Prospective Applications for β (1,3) Glucans
Recent Patents on Biotechnology The Medical Potential of Antimicrobial Peptides from Insects
Current Topics in Medicinal Chemistry Recent Advancement in Synthesis and Bioactivities of 1,3,4-Oxadiazole
Current Organic Synthesis Chelating Systems for 99mTc/188Re in the Development of Radiolabeled Peptide Pharmaceuticals
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Effects of PARP Inhibitors on Cancer and other Diseases
Current Enzyme Inhibition Control of Copper Status for Cancer Therapy
Current Cancer Drug Targets An Overview of Biotechnological Applications in Ayurveda: Amalgamation of Modern Techniques and Science
Current Traditional Medicine Structure-Based Drug Design, Molecular Dynamics and ADME/Tox to Investigate Protein Kinase Anti-Cancer Agents
Current Bioactive Compounds Pharmacological Activation of Protein Phosphatase 2 A (PP2A): A Novel Strategy to Fight Against Human Malignancies?
Current Medicinal Chemistry Lipoxins, The Novel Mediators of Gastroprotection and Gastric Adaptation to Ulcerogenic action of Aspirin
Current Pharmaceutical Design Differential Expression of TOM34, AL1A1, PADI2 and KLRBA in NNK Induced Lung Cancer in Wistar Rats and their Implications
Current Cancer Drug Targets An Evidence-Based Review of the Mechanism of Action, Efficacy, and Safety of Biologic Therapies in the Treatment of Psoriasis and Psoriatic Arthritis
Current Medicinal Chemistry The Role of XRCC4 in Carcinogenesis and Anticancer Drug Discovery
Recent Patents on Anti-Cancer Drug Discovery